↓ Skip to main content

Carbohydrate-Based Vaccines

Overview of attention for book
Attention for Chapter 14: Glycoconjugate Vaccines: The Regulatory Framework
Altmetric Badge

Readers on

mendeley
11 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Glycoconjugate Vaccines: The Regulatory Framework
Chapter number 14
Book title
Carbohydrate-Based Vaccines
Published in
Methods in molecular biology, January 2015
DOI 10.1007/978-1-4939-2874-3_14
Pubmed ID
Book ISBNs
978-1-4939-2873-6, 978-1-4939-2874-3
Authors

Christopher Jones, Jones, Christopher

Abstract

Most vaccines, including the currently available glycoconjugate vaccines, are administered to healthy infants, to prevent future disease. The safety of a prospective vaccine is a key prerequisite for approval. Undesired side effects would not only have the potential to damage the individual infant but also lead to a loss of confidence in the respective vaccine-or vaccines in general-on a population level. Thus, regulatory requirements, particularly with regard to safety, are extremely rigorous. This chapter highlights regulatory aspects on carbohydrate-based vaccines with an emphasis on analytical approaches to ensure the consistent quality of successive manufacturing lots.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 11 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 11 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 3 27%
Researcher 1 9%
Other 1 9%
Student > Postgraduate 1 9%
Unknown 5 45%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 2 18%
Chemistry 2 18%
Biochemistry, Genetics and Molecular Biology 1 9%
Medicine and Dentistry 1 9%
Unknown 5 45%